Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

chemotherapy

  • Open Access
    Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
    TAKAAKI MASUDA, HIROAKI UEO, YUTA OKUMURA, YUICHIRO KAI, YUKI ANDO, KEN MASUGUCHI, MIWA KITAGAWA, AKIHIRO KITAGAWA, NAOKI HAYASHI, YUSUKE TSURUDA, YUICHI HISAMATSU, SHUJI SUEHIRO, HIROFUMI OHMURA, KENJI FUJIYOSHI, FUMIAKI TANAKA and KOSHI MIMORI
    Cancer Genomics & Proteomics March 2023, 20 (2) 182-194; DOI: https://doi.org/10.21873/cgp.20373
  • Open Access
    Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate
    MOHAMED E. M. SAEED, CANDELA CIVES-LOSADA and THOMAS EFFERTH
    Cancer Genomics & Proteomics November 2022, 19 (6) 727-739; DOI: https://doi.org/10.21873/cgp.20355
  • Open Access
    SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy
    AHMED ADHAM RAAFAT ELSAYED, SARMAD AL-MARSOUMMI, EMILIE E. VOMHOF-DEKREY and MARC D. BASSON
    Cancer Genomics & Proteomics May 2022, 19 (3) 328-338; DOI: https://doi.org/10.21873/cgp.20323
  • You have access
    Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3
    IOANNIS PANAGOPOULOS, KRISTIN ANDERSEN, MARTINE EILERT-OLSEN, BERNWARD ZELLER, MONICA CHENG MUNTHE-KAAS, JOCHEN BUECHNER, LIV T.N. OSNES, FRANCESCA MICCI and SVERRE HEIM
    Cancer Genomics & Proteomics January 2021, 18 (1) 67-81; DOI: https://doi.org/10.21873/cgp.20242
  • Open Access
    Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer
    ONDREJ FIALA, ONDREJ SOREJS, PETR HOSEK, VACLAV LISKA, ONDREJ VYCITAL, JAN BRUHA, RADEK KUCERA, ONDREJ TOPOLCAN, JINDRICH FINEK, DIANA MACECKOVA and PAVEL PITULE
    Cancer Genomics & Proteomics September 2020, 17 (5) 605-613; DOI: https://doi.org/10.21873/cgp.20217
  • Open Access
    ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
    DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS and VASILIKI BRAVOU
    Cancer Genomics & Proteomics March 2018, 15 (2) 127-141;
  • Open Access
    Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells
    MARIAN PETROVIC, CEDRIC SIMILLION, PETER KRUZLIAK, JAN SABO and MANFRED HELLER
    Cancer Genomics & Proteomics November 2015, 12 (6) 347-358;
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire